Skip to main content

Abstract

Objective

Endophenotype studies of obsessive-compulsive disorder (OCD) may uncover heritable traits that are related to genetic susceptibility to OCD. Deficient response inhibition is a promising endophenotype of OCD, although its functional neural correlates have not been extensively studied. The authors sought to determine the functional neural correlates of response inhibition in a large sample of medication-free OCD patients and their unaffected siblings.

Method

Forty-one OCD patients, 17 of their siblings, and 37 matched healthy comparison subjects performed a stop-signal task during 3-T functional MRI. The stop-signal reaction time provided a behavioral measure of response inhibition. The neural correlates of response inhibition were assessed in a region-of-interest analysis that included the presupplementary motor area, inferior frontal gyrus, subthalamic nucleus, and inferior parietal cortex.

Results

Patients with OCD had greater stop-signal reaction times relative to healthy comparison subjects. The numerical stop-signal reaction time difference between siblings and comparison subjects failed to reach significance. Both patients with OCD and their siblings showed greater activity in the left presupplementary motor area during successful inhibition relative to comparison subjects. Relative to both the comparison subjects and the siblings, patients with OCD showed decreased activity in the right inferior parietal cortex and inferior frontal gyrus. In patients and siblings, presupplementary motor area activity correlated negatively with stop-signal reaction time.

Conclusions

These findings suggest that presupplementary motor area hyperactivity is a neurocognitive endophenotype of OCD that is possibly related to inefficient neural processing within the presupplementary motor area itself. Patients with OCD further showed a state-dependent deficit in recruiting right inferior parietal cortex and inferior frontal gyrus, which may contribute to their inhibition deficit.
Obsessive-compulsive disorder (OCD) is a debilitating psychiatric disorder affecting 2%–3% of the general population (1) that is characterized by time-consuming obsessions (repetitive intrusive thoughts) and compulsions (repetitive ritualistic behaviors). OCD has a partially genetic etiology, with twin studies indicating a heritability of OCD symptoms in adults ranging from 27% to 45% and first-degree relatives of patients having four times the risk for developing OCD symptoms relative to family members of comparison subjects (2). Genome-wide linkage studies of OCD suggest susceptibility loci on several chromosomes (3), which is in line with the supposed involvement of multiple genetic polymorphisms related to dopaminergic, serotonergic, and glutamatergic neurotransmission and neuronal outgrowth and myelination (2, 4). Like most neuropsychiatric disorders (5), OCD has a complex genetic background, with probably several environmental and epigenetic factors interacting with multiple genes to give rise to a heterogeneous phenotype. Phenotypical categorization into OCD subdimensions has only been partially useful to the genetic study of OCD (6, 7).
To obtain a better understanding of the etiological underpinnings of OCD, therefore, a search for endophenotypes of the disorder is warranted (8). An endophenotype is “a measurable trait along the path between phenotype and distal genotype, reflecting a simpler clue to the genetic basis of a disorder than the syndrome itself, and thus can help clarify the exact genetic contributions to a disease” (5). One candidate endophenotype of OCD is impaired response inhibition as measured by the stop-signal task (8). Response inhibition is the process by which a motor action is withheld upon the appearance of a stop signal. Problems with inhibition are apparent in the phenomenology of OCD, with patients seemingly unable to stop their obsessions and compulsions. Indeed, patients with OCD and their first-degree relatives share a lengthened duration of the inhibitory process—i.e., their stop-signal reaction time is elevated (9, 10). A meta-analysis (11) has shown that this inhibition deficit may be a more prominent feature of OCD when compared with other related disorders such as Tourette’s syndrome or anxiety and mood disorders.
Response inhibition is associated with a core network comprising the presupplementary motor area, the inferior frontal gyrus, and the subthalamic nucleus (1214). There is, however, also robust evidence for the involvement of the inferior parietal cortex in inhibition from studies in healthy subjects and patient groups showing inhibition impairments (10, 1418). The exact role of the above-mentioned regions in the subsequent steps of response inhibition (i.e., attentional monitoring of the stop signal, resolving the response conflict, and inhibiting a prepotent motor response) is still up for debate (12, 14). The behavioral inhibition deficit in OCD patients and their first-degree relatives is associated with widespread gray matter density increases in cingulo-parietal regions and decreases in frontal regions (10). Furthermore, a diffusion tensor imaging study of the same sample of patients and relatives (19) indicated white matter integrity changes with a similar spatial pattern in the right inferior parietal cortex and the medial frontal cortex. It remains unclear to what extent these morphological changes are functionally related to the inhibition deficit seen in OCD patients and relatives.
Neurobiological models of OCD have implicated dysfunctional frontal-striatal loops in the etiology of clinical symptoms and cognitive deficits (20). An imbalance between hypoactive brain areas associated with cognitive control and hyperactive brain areas associated with the processing of errors (i.e., the anterior cingulate cortex) is thought to underlie the inhibitory dysfunction and increased error sensitivity found in OCD patients (2022). This frontal-striatal model of OCD was revised as the involvement of other regions such as the parietal cortex became increasingly clear (20). The four functional neuroimaging studies conducted to date on response inhibition in OCD have produced inconsistent results. Task-related activity in the inferior frontal gyrus (2326) and the premotor cortex (24, 26), possibly extending to the presupplementary motor area, and anterior cingulate cortex (23, 26) was found to be both increased and decreased in patients relative to comparison subjects. These inconsistent findings may result from methodological constraints such as limited power, age differences, and medication confounds.
Although the inhibition deficit is thought to be an important endophenotype of OCD (8), to our knowledge no study has investigated the functional neural correlates of response inhibition as a trait marker of OCD in unaffected first-degree relatives. We assessed this in a large sample of medication-free adult OCD patients and their unaffected siblings to derive a neurocognitive endophenotype for OCD. Based on the reviewed evidence, we hypothesized that impaired response inhibition in OCD patients and their siblings is related to the aberrant recruitment of the presupplementary motor area, inferior frontal gyrus, subthalamic nucleus, and inferior parietal cortex. In addition, we hypothesized that patients and siblings would show greater recruitment of the anterior cingulate cortex during error processing.

Method

Participants

Forty-five medication-free patients with OCD, 17 of their siblings, and 39 healthy comparison subjects participated in the study (see Table 1 for a summary of demographic characteristics). Four patients and two comparison subjects were excluded from the analysis for various reasons (see section S1.1 in the data supplement that accompanies the online edition of this article). Patients and siblings were recruited through outpatient clinics within the Netherlands OCD Association consortium (http://nocda.amstad.nl) and the Academic Anxiety Center Altrecht (Utrecht, the Netherlands) and by online advertisements. Comparison subjects were recruited by local and online community advertisements.
TABLE 1. Demographic, Clinical, and Behavioral Characteristics of Patients With OCD, Unaffected Siblings, and Healthy Comparison Subjects
 OCD Patients (N=41)Siblings (N=17)Comparison Subjects (N=37)Analysis
CharacteristicsN%N%N%χ2 (df=2)p
Demographic measures        
Gender (men)2151127118492.40.297
Handedness (right)3585137732861.00.622
 MeanSDMeanSDMeanSDF (df=2, 92)p
Age (years)38.69.838.313.439.711.60.10.871
Education levela5.91.95.71.35.91.90.2b0.896
Clinical measures        
Yale-Brown Obsessive Compulsive Scale21.96.10.10.20.0083.8b<0.001
Obsessive-Compulsive Inventory–Revised        
 Total score24.412.04.11.13.24.862.4b<0.001
 Washing score3.23.90.20.40.30.621.7b<0.001
 Checking score6.03.60.60.80.50.955.8b<0.001
 Symmetry score4.93.80.81.30.81.533.3b<0.001
Montgomery-Åsberg Depression Rating Scale score11.58.11.93.50.81.051.8b<0.001
Behavioral measures        
Stop-signal reaction time (ms)204.945.0198.437.2184.243.22.40.100
Mean go-trial reaction time (ms)694.7107.4738.9160.0675.5140.81.40.263
Errors on go trials (%)1.01.31.82.40.81.01.8b0.412
a
Education level was recorded in nine levels ranging from 1 (no finished education) to 9 (university training).
b
Kruskal-Wallis test, H (df=2, 92).
We screened all participants for axis I psychiatric disorders with the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (27). OCD symptom characteristics and severity were assessed with the Obsessive-Compulsive Inventory–Revised (28) and the Yale-Brown Obsessive Compulsive Scale (29), respectively. Participant mood was assessed with the Montgomery-Åsberg Depression Rating Scale (MADRS) (30), and handedness was assessed with the Edinburgh Handedness Inventory (31). All participants were between 18 and 65 years old and had normal or corrected-to-normal vision.
Exclusion criteria were psychoactive medication use, current or past psychosis, a major physical illness, a history of a major neurological illness, or MRI contraindications. The OCD patients were medication free for at least 4 weeks, and they could participate if they had a primary diagnosis of OCD without predominant hoarding. Psychiatric comorbidity (including tic disorders) was not an exclusion criterion. Siblings did not meet criteria for OCD, and comparison subjects had no current DSM-IV-TR axis I diagnosis and no family history of OCD. All procedures were approved by the local ethical review board, and all subjects provided written informed consent.

Stop-Signal Task

The participants performed a visual stop-signal task (32) during functional MRI (fMRI), in which they indicated the direction of an arrow with a button press. Eighty percent of the trials were simple go trials. Unpredictably, on 20% of the trials, a stop signal (cross) appeared with a delay after the arrow. This stop-signal delay was updated such that the stop-success-to-error ratio was approximately 50%. Behavioral outcome measures were the subject-specific stop-signal reaction time (speed of the stop process), the mean reaction time on accurate go trials (speed of go process), and the error percentage on go trials (overall attention; see section S1.2 of the online data supplement for further task specifications).

Behavioral Analyses

We analyzed the group effects on demographic, clinical, and behavioral measures by one-way analysis of variance (ANOVA) with SPSS, version 15 (Chicago, 2006). Statistical significance was set at p<0.05, two-tailed. Significant group interactions and trends (0.05≤p≤0.10) were followed up by post hoc two-sample t tests. If data did not meet parametric assumptions, we used nonparametric tests as indicated. We assessed group effects on gender and handedness with chi-square tests. To assess whether clinical variables (i.e., disease severity and MADRS scores for patients and Obsessive-Compulsive Inventory–Revised scores for siblings) influenced task performance, we performed correlation analyses.

Image Acquisition

Imaging was done on a GE Signa HDxt 3-T MRI scanner (General Electric, Milwaukee) at the VU University Medical Center. Functional images were acquired with a gradient echo-planar imaging sequence (TR=2,100 ms; TE=30 ms; 64×64 matrix; field of view=24 cm; flip angle=80°) with 40 ascending slices per volume (3.75×3.75 mm in-plane resolution; slice thickness=2.8 mm; interslice gap=0.2 mm), which gave whole-brain coverage. Structural scanning included a sagittal three-dimensional gradient-echo T1-weighted sequence (256×256 matrix; voxel size=1×0.977×0.977 mm; 172 sections).

Image Processing and Analyses

Functional images were analyzed with SPM8 (Wellcome Trust Centre for Neuroimaging, London). To minimize motion-related artifacts, images were reoriented and realigned. The high-resolution structural T1 scan was coregistered with the mean functional image and spatially warped to the Montreal Neurological Institute (MNI) T1 template. This normalization matrix was applied to the functional images. Data were resliced with a 3×3×3 mm resolution and spatially smoothed with an 8 mm full width at half maximum Gaussian kernel.
Imaging data were analyzed in the context of the general linear model. At the first level, onsets of accurate go trials, stop-success trials, and stop-error trials were modeled using delta functions convolved with the canonical hemodynamic response function. Participants’ movement parameters were included in the model as regressors of no interest. To remove low-frequency noise, a high-pass filter (128-second cutoff period) was applied.
The inhibition contrast (stop-success trials > go trials) was calculated for each subject to probe blood-oxygen-level-dependent (BOLD) activity related to inhibition. To assess error processing, an error contrast was constructed (stop-error trials > stop-success trials). These two first-level contrast images were brought into second-level random-effects analyses.
A priori hypotheses were tested in specific regions of interest associated with response inhibition and error monitoring, respectively. Using MarsBaR (http://marsbar.sourceforge.net), 10 mm spherical functional regions of interest were created around the peak voxel coordinates of the main effect of inhibition and error over all subjects (N=95; see Tables S2A and S2B in the online data supplement) examined at p<0.05, whole-brain family-wise error corrected (33). The inhibition-related regions of interest were the left and right inferior frontal gyrus (Brodmann’s areas [BAs] 47/45/13; right: x=33, y=23, z=−11; left: x=−33, y=23, z=−8), inferior parietal cortex (BA 40; right: x=42, y=−55, z=43; left: x=−51, y=−55, z=43), presupplementary motor area (BA 6; right: x=9, y=17, z=67; left: x=−15, y=14, z=67), and subthalamic nucleus (x=3, y=−15, z=−2). An error-related anterior cingulate cortex region of interest was constructed around coordinates x=0, y=20, z=34.
Main effects of task were assessed in one-sample t tests per group per contrast. The 41 OCD patients were directly compared with the 37 comparison subjects in a two-sample t test per contrast. To specifically test the 17 patient-sibling pairs, a three-group comparison (one-way ANOVA [N=51]) was performed that also included 17 comparison subjects as a specific age-, gender-, and education-matched comparison group. Group interactions from this ANOVA were followed up by post hoc two-sample t tests. To ensure that group differences in BOLD activity were truly a reflection of genetic susceptibility to OCD, instead of differences in task performance we included stop-signal reaction time as a covariate of no interest in all the analyses. Moreover, because six sibling-patient pairs were discordant for gender, we included gender as a covariate. Imaging results were considered significant when controlled for type I errors for the search volume (p<0.05, family-wise error corrected).
We extracted the peak voxel activity of all clusters of between-group differences. Correlations were then calculated between these values and behavioral (all groups) and clinical measures (within patients and siblings). Results are reported using Pearson’s r unless otherwise indicated.

Results

Demographic and Clinical Characteristics

The three groups were well matched on demographic characteristics (see Table 1). A main effect of group was observed on all clinical variables that was caused by patients having higher scores relative to both comparison subjects and siblings (p<0.01), whereas siblings did not significantly differ from comparison subjects.
All patients had been medication free for at least 4 weeks before the study began. All patients except two had used medication previously. Twenty-two patients (54%) met criteria for one or more current axis I diagnosis aside from OCD (see section S2.1 in the online data supplement). Patients with (N=22) or without (N=19) comorbid diagnoses did not differ significantly on demographic, clinical, or behavioral measures.
The groups included in the three-group comparison (N=17 in each group) did not differ on demographic characteristics, nor did these smaller samples differ from the complete samples of patients and comparison subjects, respectively (p>0.10, see section S2.2 and Table S1 in the online data supplement).

Behavioral Results

Between-group effects.

A main effect of group on stop-signal reaction time that fell short of significance was observed at trend level (see Table 1 and Figure 1). Post hoc tests revealed significantly greater stop-signal reaction times in patients relative to comparison subjects (t=2.07, df=76, p=0.04). The difference between siblings and patients or siblings and comparison subjects on stop-signal reaction time, as well as the difference between groups on go-trial reaction time and error percentage, did not reach significance.
FIGURE 1. Box Plot With Stop-Signal Reaction Time (SSRT) of Patients With OCD, Unaffected Siblings, and Healthy Comparison Subjectsa
a The difference between OCD patients and comparison subjects reached significance (t=2.07, df=76, p=0.04), but the difference between unaffected siblings and comparison subjects did not (t=1.33, df=52, p=0.18). The thick bar indicates median; the box represents interquartile range.

Correlation analysis of task performance and clinical measures.

There were no significant correlations between behavioral measures (stop-signal reaction time, go-trial reaction time, or error percentage), and disease severity and MADRS scores in patients, and Obsessive-Compulsive Inventory–Revised scores in siblings.

fMRI Results

Within-group effects.

The main effects of inhibition and error were similar across the groups (see Figure 2 and Table S3 in the online data supplement). During inhibition, all regions of interest were activated in all groups, with the exception of the left presupplementary motor area, which was significantly activated only in patients and siblings. The anterior cingulate cortex was activated bilaterally in all groups during error processing.
FIGURE 2. Main Effect of Inhibition Over All Subjects (N=95)a
a T statistic image of stop-success trials > go trials contrast over all subjects (N=95), threshold set at p<0.05, whole-brain family-wise error corrected, overlain on ch2better MNI template with MRIcron (http://www.mccauslandcenter.sc.edu/mricro/mricron). T values are displayed from red (T=4.71, threshold) to yellow (T>10). Coordinates are in MNI space. S=superior; P=posterior; L=left; A=anterior.

Between-group effects.

Relative to comparison subjects, OCD patients showed greater activity in the left presupplementary motor area and lower activity in the right inferior parietal cortex during inhibition (see Table 2 and Figure 3). Patients also showed lower activity in the right inferior frontal gyrus, but only at a more lenient threshold. The three-group comparison (see Table 3 and Figure 3) revealed that siblings shared left presupplementary motor area hyperactivity with patients. Furthermore, presupplementary motor area hyperactivity in siblings was bilateral. Activity in the right inferior parietal cortex and the inferior frontal gyrus was lower during inhibition in patients than in siblings, in whom these regions were activated at the same level as comparison subjects. No differences in error-related anterior cingulate cortex activity were observed between the groups.
TABLE 2. Group Interactions During Inhibition in Patients With OCD (N=41) and Healthy Comparison Subjects (N=37)
Interaction   Coordinates   
RegionSideBrodmann’s AreaxyzkezpFWE
OCD patients > comparison subjectsaPresupplementary motor areaLeft6−151761163.270.013
Comparison subjects > OCD patientsaInferior parietal cortexRight4042−493783.360.010
 Inferior frontal gyrusbRight473029−532.700.056
a
Two-sample t test.
b
pFWE<0.10; FWE=family-wise error corrected.
FIGURE 3. Group Interactions During Inhibition and Relationship With Stop-Signal Reaction Time (SSRT) and Disease Severity in OCD Patientsa
a Panel A shows increased presupplementary motor area activity in patients with OCD and siblings relative to comparison subjects. Panel B shows the parameter estimate per group of left presupplementary motor area peak voxel. Panel C is a scatterplot showing negative correlation of stop-signal reaction time and left presupplementary motor area activity in patients. Panel D is a scatterplot showing negative correlation of disease severity and right presupplementary motor area activity in patients. Panel E shows decreased activity of right inferior parietal cortex in patients with OCD relative to comparison subjects and siblings. Panel F shows the parameter estimate per study group of right inferior parietal cortex peak voxel. All group interaction clusters are overlain on ch2better MNI template in MRIcron, and image threshholds are set at family-wise error corrected for p<0.10 for illustration purposes. Parameter estimates are in arbitrary units.
TABLE 3. Group Interactions During Inhibition in the Three-Group Comparison Including 17 Patient-Sibling Pairs and 17 Matched Comparison Subjectsa
 CoordinatesMain Effect of GroupbSiblings > OCD PatientscSiblings > Comparison Subjectsc
Region (Side, Brodmann’s Area)xyzkezpFWEkezpFWEkezpFWE
Presupplementary motor area (left, BA 6)−12146183.320.015      
 −121761      273.630.005
 −1556712.890.048   33.070.027
Presupplementary motor area (right, BA 6)151764      32.930.040
Inferior parietal cortex (right, BA 40)36−614663.120.027      
 36−5846   254.140.001   
Inferior frontal gyrus (right, BA 47)3323−8   53.170.023   
a ke=cluster size; pFWE,=family-wise error corrected p value for search volume. Coordinates are in MNI space. Inhibition-contrast: stop-success-trials > go-trials.
b Three-group ANOVA.
c Post hoc two-sample t test.

Correlations of brain activity with behavioral and clinical measures.

In patients with OCD, stop-signal reaction time correlated negatively with left presupplementary motor area activity (r=−0.33, df=39, p=0.03; see Figure 3C) and positively with right inferior parietal cortex activity (coordinates: x=42, y=−49, z=37; r=0.37, df=39, p=0.02). Disease severity scores correlated negatively with right presupplementary motor area activity (r=−0.38, df=39, p=0.02; see Figure 3D), and go-trial reaction time correlated positively with right inferior frontal gyrus activity (coordinates: x=30, y=29, z=−5; r=0.49, df=39, p=0.001). In siblings, stop-signal reaction time correlated negatively with right presupplementary motor area activity (rs=−0.48, df=15, p=0.05), and total Obsessive-Compulsive Inventory–Revised score correlated negatively with right inferior parietal cortex activity (rs=−0.56, df=15, p=0.02).
MADRS scores did not correlate with regional brain activity. Brain activity did not differ between patients with and without comorbid diagnoses, and exclusion of patients with comorbid depression did not affect the results (data not shown).

Discussion

We assessed the functional neural correlates of response inhibition in a large sample of medication-free patients with OCD, their unaffected siblings, and healthy comparison subjects without a family history of OCD. Both patients and their siblings showed behaviorally impaired response inhibition, although for siblings this did not reach statistical significance. Also, both patients and their siblings showed increased recruitment of the presupplementary motor area during inhibition, suggesting that hyperactivity in the presupplementary motor area is a candidate neurocognitive endophenotype of OCD. Moreover, patients showed decreased recruitment of the right inferior parietal cortex and inferior frontal gyrus during inhibition relative to their siblings and the healthy comparison subjects, which possibly contributes to the impairment in response inhibition.
Impaired response inhibition at the behavioral level is consistent with previous studies of OCD patients and their relatives (9, 10). Left presupplementary motor area hyperactivity in OCD patients and their unaffected siblings during response inhibition is a novel finding. Studies of healthy subjects have provided strong evidence for the key importance of the presupplementary motor area for the rapid resolution of conflicting action plans, which is necessary for adequate stop-signal task performance (12, 34). The negative correlation between stop-signal reaction time and presupplementary motor area activity in OCD patients and their siblings, with high activity in the presupplementary motor area related to relatively preserved stop-signal task performance, has been reported in healthy subjects (12, 17, 34). Furthermore, disruption of left presupplementary motor area functioning has been found to result in increased stop-signal reaction time in human participants (35), and microstimulation studies in monkeys have shown that the presupplementary motor area is critical for inhibition by suppressing the unwanted action and facilitating the desired one (36). Thus, the presupplementary motor area is important for inhibition in healthy subjects, and we found here that its activity also correlates with performance in OCD patients and their siblings.
Medial frontal cortex abnormalities are an important feature of OCD-related brain changes (20). Neuroimaging studies (20, 21, 23, 37, 38) using fMRI, positron emission tomography, and magneto- and electroencephalography have provided evidence for medial frontal hyperactivity in OCD during task performance, which, although most studies focused on changes in the anterior cingulate cortex, sometimes extended to the presupplementary motor area (39). In addition, biochemical and structural changes in the medial frontal cortex have been observed in patients with OCD and their relatives (10, 19, 20, 39) and have been found to be correlated with impaired response inhibition (10). Thus, given the behavioral relevance of presupplementary motor area activity and previous reports of regional structural changes, hyperactivity in patients and siblings may be a compensatory mechanism, with a spreading or increase of regional brain activity reflecting inefficient neural processing of the presupplementary motor area itself. The negative correlation between right presupplementary motor area activity and illness severity in patients further suggests that this compensatory mechanism is failing in severe OCD.
Although we observed no group differences in error monitoring, many studies have associated medial frontal cortex abnormalities in OCD with increased error monitoring (21, 23, 37, 38). None of these studies, however, showed a clear relationship between brain activation and conflict load or error-related behavior. For instance, results from an EEG study (38) showing increased error-related negativity after error trials in patients with OCD and their relatives were no longer significant after controlling for baseline amplitude. A recent magnetoencephalography study on error monitoring in patients with OCD instead suggested that the observed anterior frontal cortex hyperactivity was compensatory (40). Taken together with our results, this suggests that frontal midline hyperactivity in OCD is related to a more general increased compensatory recruitment rather than being specific for error signals. Furthermore, based on the available literature on inhibition and conflict monitoring, we expect that presupplementary motor area hyperactivity during inhibition is specifically present in groups who are at risk for developing OCD and not in non-OCD anxiety (11, 41). This hypothesis, however, awaits empirical confirmation.
We observed deficient recruitment of the right inferior parietal cortex and inferior frontal gyrus during response inhibition in OCD patients relative to comparison subjects, a finding that was absent in siblings. Hypoactivity in the inferior parietal cortex and inferior frontal gyrus in patients could reflect impaired attention to the stop signal or impaired action reprogramming (10, 12, 13, 15, 17). We found no evidence for a general attentional deficit in patients, since go trial performance was not affected. Although hypoactivity in the right inferior frontal gyrus was significant only at the subthreshold level, this finding is consistent with previous studies on response inhibition in OCD (2426). Hypoactivity of the right inferior parietal cortex during mental imagery in OCD has been reported (42); however, this study is the first to observe it during response inhibition.
Abnormalities in parietal cortex functioning in OCD may be related to regional structural brain changes previously observed in patients and relatives that correlated with impaired response inhibition (10, 19, 20). In our study, however, activity in the inferior parietal cortex (and the inferior frontal gyrus) in siblings was unaffected at the group level, even when explored at a very lenient statistical threshold. We did observe a significant negative correlation between inferior parietal cortex activity and OCD symptom scores in siblings, suggesting that siblings with more subclinical OCD symptoms have a failure of inferior parietal cortex recruitment that is similar to OCD patients. This state dependency of parietal activity in OCD is consistent with the decreased inferior parietal cortex activity during planning observed in twins with high compared with low subclinical OCD symptoms (43).
The positive correlation in patients between stop-signal reaction time and right inferior parietal cortex activity replicates previous findings of a positive correlation between stop-signal reaction time and inferior parietal cortex activity in healthy subjects and inferior parietal cortex structure in OCD patients and their relatives (10, 17). Our results further confirm the functional involvement of the inferior parietal cortex in response inhibition. The combination of both inferior parietal cortex hypoactivity in patients and a positive relationship of activity in the inferior parietal cortex with stop-signal reaction time in this group, however, seems counterintuitive, and its explanation is not straightforward. Possibly, increased parietal recruitment during stop-success trials in poor-performing patients reflects an up-regulation of the default mode network, as has been previously suggested (17). Although the subthalamic nucleus is important for inhibition (12) and its firing pattern seems dysfunctional in OCD patients (44), we, like previous OCD inhibition researchers (2326), did not find any group interactions in this region. Future studies should elucidate the exact roles of the inferior parietal cortex and inferior frontal gyrus in inhibitory control and their dysfunction in OCD, and they should replicate our findings.
A limitation of our study is that although gender ratios between the groups were not statistically different, six of the 17 patient-sibling pairs were discordant for gender. Recruiting siblings instead of other first-degree relatives, such as parents, has the benefit of including subjects within a similar age range. Age-dependent effects on response inhibition have been described, so age matching, which was achieved in this study, is important. Because we included gender as a covariate in the analyses, we expect that our group-interaction effects cannot be attributed to gender.
This is the first study to identify trait-dependent compensatory hyperactivity in the presupplementary motor area during response inhibition in both medication-free OCD patients and their unaffected siblings, possibly related to inefficiencies in neural processing within the presupplementary motor area itself. State-dependent effects on the recruitment of the right inferior parietal cortex and inferior frontal gyrus during inhibition might further contribute to the inhibition deficit in OCD. These results support the notion that impaired response inhibition is a candidate endophenotype of OCD and localize its associated neural correlate in the presupplementary motor area.

Acknowledgments

The authors thank Vionne van der Borden, M.Sc., Chris Vriend, M.Sc., and Sander J.C. Verfaillie, M.Sc., for their help during the MRI scan sessions.

Footnotes

Presented in part at the 17th annual meeting of the Organization for Human Brain Mapping, Quebec City, Quebec, Canada, June 26–30, 2011.
Supported in part by the Netherlands Society for Scientific Research (NWO-ZonMw VENI grant 916.86.036 to Dr. van den Heuvel; NWO-ZonMw AGIKO stipend 920-03-542 to Dr. de Vries), a NARSAD Young Investigators Award to Dr. van den Heuvel, Amsterdam Brain Imaging Platform to Dr. van den Heuvel, the Netherlands Brain Foundation (2010(1)-50 to Dr. van den Heuvel), and Stichting tot Steun VCVGT (STO957 to Dr. Cath).

Supplementary Material

Supplementary Material (1100_ds001.pdf)

References

1.
Ruscio AM, Stein DJ, Chiu WT, Kessler RC: The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010; 15:53–63
2.
Pauls DL: The genetics of obsessive compulsive disorder: a review of the evidence. Am J Med Genet C Semin Med Genet 2008; 148C:133–139
3.
Shugart YY, Samuels J, Willour VL, Grados MA, Greenberg BD, Knowles JA, McCracken JT, Rauch SL, Murphy DL, Wang Y, Pinto A, Fyer AJ, Piacentini J, Pauls DL, Cullen B, Page J, Rasmussen SA, Bienvenu OJ, Hoehn-Saric R, Valle D, Liang KY, Riddle MA, Nestadt G: Genome-wide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry 2006; 11:763–770
4.
Katerberg H, Lochner C, Cath DC, de Jonge P, Bochdanovits Z, Moolman-Smook JC, Hemmings SM, Carey PD, Stein DJ, Sondervan D, Boer JA, van Balkom AJ, Polman A, Heutink P: The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD). Am J Med Genet B Neuropsychiatr Genet 2009; 150B:1050–1062
5.
Gottesman II, Gould TD: The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160:636–645
6.
Miguel EC, Leckman JF, Rauch S, do Rosario-Campos MC, Hounie AG, Mercadante MT, Chacon P, Pauls DL: Obsessive-compulsive disorder phenotypes: implications for genetic studies. Mol Psychiatry 2005; 10:258–275
7.
Mataix-Cols D: Deconstructing obsessive-compulsive disorder: a multidimensional perspective. Curr Opin Psychiatry 2006; 19:84–89
8.
Chamberlain SR, Menzies L: Endophenotypes of obsessive-compulsive disorder: rationale, evidence and future potential. Expert Rev Neurother 2009; 9:1133–1146
9.
Chamberlain SR, Fineberg NA, Menzies LA, Blackwell AD, Bullmore ET, Robbins TW, Sahakian BJ: Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. Am J Psychiatry 2007; 164:335–338
10.
Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen CH, del Campo N, Sahakian BJ, Robbins TW, Bullmore E: Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007; 130:3223–3236
11.
Lipszyc J, Schachar R: Inhibitory control and psychopathology: a meta-analysis of studies using the stop signal task. J Int Neuropsychol Soc 2010; 16:1064–1076
12.
Aron AR: From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol Psychiatry 2011; 69:e55–e68
13.
Boehler CN, Appelbaum LG, Krebs RM, Hopf JM, Woldorff MG: Pinning down response inhibition in the brain: conjunction analyses of the stop-signal task. Neuroimage 2010; 52:1621–1632
14.
Chikazoe J: Localizing performance of go/no-go tasks to prefrontal cortical subregions. Curr Opin Psychiatry 2010; 23:267–272
15.
Mars RB, Piekema C, Coles MG, Hulstijn W, Toni I: On the programming and reprogramming of actions. Cereb Cortex 2007; 17:2972–2979
16.
Garavan H, Ross TJ, Stein EA: Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci USA 1999; 96:8301–8306
17.
Congdon E, Mumford JA, Cohen JR, Galvan A, Aron AR, Xue G, Miller E, Poldrack RA: Engagement of large-scale networks is related to individual differences in inhibitory control. Neuroimage 2010; 53:653–663
18.
Mulligan RC, Knopik VS, Sweet LH, Fischer M, Seidenberg M, Rao SM: Neural correlates of inhibitory control in adult attention deficit/hyperactivity disorder: evidence from the Milwaukee longitudinal sample. Psychiatry Res 2011; 194:119–129
19.
Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J, Sahakian BJ, Robbins TW, Bullmore ET: White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am J Psychiatry 2008; 165:1308–1315
20.
Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET: Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 2008; 32:525–549
21.
Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, Taylor SF: Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 2005; 57:287–294
22.
van den Heuvel OA, Veltman DJ, Groenewegen HJ, Cath DC, van Balkom AJ, van Hartskamp J, Barkhof F, van Dyck R: Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry 2005; 62:301–309
23.
Maltby N, Tolin DF, Worhunsky P, O’Keefe TM, Kiehl KA: Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: an event-related fMRI study. Neuroimage 2005; 24:495–503
24.
Roth RM, Saykin AJ, Flashman LA, Pixley HS, West JD, Mamourian AC: Event-related functional magnetic resonance imaging of response inhibition in obsessive-compulsive disorder. Biol Psychiatry 2007; 62:901–909
25.
Woolley J, Heyman I, Brammer M, Frampton I, McGuire PK, Rubia K: Brain activation in paediatric obsessive compulsive disorder during tasks of inhibitory control. Br J Psychiatry 2008; 192:25–31
26.
Page LA, Rubia K, Deeley Q, Daly E, Toal F, Mataix-Cols D, Giampietro V, Schmitz N, Murphy DG: A functional magnetic resonance imaging study of inhibitory control in obsessive-compulsive disorder. Psychiatry Res 2009; 174:202–209
27.
First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York, NY, Biometrics Research, New York State Psychiatric Institute, 2002
28.
Foa EB, Huppert JD, Leiberg S, Langner R, Kichic R, Hajcak G, Salkovskis PM: The Obsessive-Compulsive Inventory: development and validation of a short version. Psychol Assess 2002; 14:485–496
29.
Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR, Charney DS: The Yale-Brown Obsessive Compulsive Scale–II: Validity. Arch Gen Psychiatry 1989; 46:1012–1016
30.
Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134:382–389
31.
Oldfield RC: The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971; 9:97–113
32.
Logan GD: On the ability to inhibit thought and action: a users’ guide to the stop signal paradigm, in Inhibitory Processes in Attention, Memory, and Language., Dagenbach D, Carr TH. San Diego, Calif, Academic Press, 1994, pp 189–239
33.
Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC: A unified statistical approach for determining significant signals in images of cerebral activation. Hum Brain Mapp 1996; 4:58–73
34.
Chao HH, Luo X, Chang JL, Li CS: Activation of the pre-supplementary motor area but not inferior prefrontal cortex in association with short stop signal reaction time: an intra-subject analysis. BMC Neurosci 2009; 10:75
35.
Chen CY, Muggleton NG, Tzeng OJ, Hung DL, Juan CH: Control of prepotent responses by the superior medial frontal cortex. Neuroimage 2009; 44:537–545
36.
Isoda M, Hikosaka O: Switching from automatic to controlled action by monkey medial frontal cortex. Nat Neurosci 2007; 10:240–248
37.
Ursu S, Stenger VA, Shear MK, Jones MR, Carter CS: Overactive action monitoring in obsessive-compulsive disorder: evidence from functional magnetic resonance imaging. Psychol Sci 2003; 14:347–353
38.
Riesel A, Endrass T, Kaufmann C, Kathmann N: Overactive error-related brain activity as a candidate endophenotype for obsessive-compulsive disorder: evidence from unaffected first-degree relatives. Am J Psychiatry 2011; 168:317–324
39.
Yücel M, Harrison BJ, Wood SJ, Fornito A, Wellard RM, Pujol J, Clarke K, Phillips ML, Kyrios M, Velakoulis D, Pantelis C: Functional and biochemical alterations of the medial frontal cortex in obsessive-compulsive disorder. Arch Gen Psychiatry 2007; 64:946–955
40.
Ciesielski KT, Rauch SL, Ahlfors SP, Vangel ME, Wilhelm S, Rosen BR, Hämäläinen MS: Role of medial cortical networks for anticipatory processing in obsessive-compulsive disorder. Hum Brain Mapp 2012; 33:2125–2134
41.
Xiao Z, Wang J, Zhang M, Li H, Tang Y, Wang Y, Fan Q, Fromson JA: Error-related negativity abnormalities in generalized anxiety disorder and obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35:265–272
42.
Koçak OM, Özpolat AY, Atbaşoğlu C, Çiçek M: Cognitive control of a simple mental image in patients with obsessive-compulsive disorder. Brain Cogn 2011; 76:390–399
43.
den Braber A, Ent D, Blokland GA, van Grootheest DS, Cath DC, Veltman DJ, de Ruiter MB, Boomsma DI: An fMRI study in monozygotic twins discordant for obsessive-compulsive symptoms. Biol Psychol 2008; 79:91–102
44.
Piallat B, Polosan M, Fraix V, Goetz L, David O, Fenoy A, Torres N, Quesada JL, Seigneuret E, Pollak P, Krack P, Bougerol T, Benabid AL, Chabardès S: Subthalamic neuronal firing in obsessive-compulsive disorder and Parkinson disease. Ann Neurol 2011; 69:793–802

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 1100 - 1108
PubMed: 23032388

History

Received: 16 January 2012
Revision received: 2 March 2012
Revision received: 2 April 2012
Accepted: 9 April 2012
Published online: 1 October 2012
Published in print: October 2012

Authors

Details

Stella J. de Wit, M.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Froukje E. de Vries, M.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Ysbrand D. van der Werf, Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Danielle C. Cath, M.D., Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Dirk J. Heslenfeld, Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Eveline M. Veltman, M.Sc.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Anton J.L.M. van Balkom, M.D., Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Dick J. Veltman, M.D., Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.
Odile A. van den Heuvel, M.D., Ph.D.
From the Departments of Psychiatry and Anatomy and Neuroscience, VU University Medical Center, Amsterdam, the Netherlands; the Department of Psychology, VU University, Neuroscience Campus Amsterdam; Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam; Altrecht Academic Anxiety Center, Utrecht, the Netherlands; and the Division of Clinical and Health Psychology, Utrecht University, Utrecht.

Notes

Address correspondence to Dr. de Wit ([email protected]).

Funding Information

Dr. Cath receives lecture fees from Pfizer. The remaining authors report no financial relationships with commercial interests.
Supplementary Material

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share